Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board Notice of Meetings, 18344 [2019-08695]

Download as PDF 18344 Federal Register / Vol. 84, No. 83 / Tuesday, April 30, 2019 / Notices Because the meeting is being held in a government building, a photo I.D. must be presented at the guard’s desk as a part of the clearance process. To prevent delays, you should allow an additional 30 minutes before the meeting begins to clear security. Any member of the public seeking additional information should contact Dr. Block, Designated Federal Officer, at (202) 443–5600, or by email at karen.block@ va.gov. Dated: April 25, 2019. LaTonya L. Small, Federal Advisory Committee Management Officer. Advisory Committee Act that the subcommittees of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board (JBL/CS SMRB) will meet from 8 a.m. to 5 p.m. on the dates indicated below (unless otherwise listed): [FR Doc. 2019–08696 Filed 4–29–19; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board Notice of Meetings The Department of Veterans Affairs (VA) gives notice under Federal Subcommittee Date Location Oncology-A/D ........................................................... Cellular & Molecular Medicine .................................. Endocrinology-A ....................................................... Neurobiology-C ......................................................... Mental Health & Behavioral Sciences-A .................. Oncology-B/E ............................................................ Surgery ..................................................................... Cardiovascular Studies-A ......................................... Infectious Diseases-A ............................................... Oncology-C ............................................................... Endocrinology-B ....................................................... Immunology & Dermatology-A ................................. Neurobiology-B ......................................................... Infectious Diseases-B ............................................... Pulmonary Medicine ................................................. Gulf War Research ................................................... Neurobiology-A ......................................................... Neurobiology-E ......................................................... Gastroenterology ...................................................... Nephrology ............................................................... * Neurobiology-F ....................................................... Cardiovascular Studies-B ......................................... Epidemiology ............................................................ Mental Health & Behavioral Sciences-B .................. Hematology ............................................................... Neurobiology-D ......................................................... Eligibility .................................................................... May 17, 2019 ...................................... May 20, 2019 ...................................... May 21, 2019 ...................................... May 21, 2019 ...................................... May 22, 2019 ...................................... May 22, 2019 ...................................... May 22, 2019 ...................................... May 23, 2019 ...................................... May 23, 2019 ...................................... May 23, 2019 ...................................... May 29, 2019 ...................................... May 29, 2019 ...................................... May 29, 2019 ...................................... May 30, 2019 ...................................... May 30, 2019 ...................................... May 30, 2019 ...................................... May 31, 2019 ...................................... May 31, 2019 ...................................... June 4, 2019 ....................................... June 4, 2019 ....................................... June 5, 2019 ....................................... June 6, 2019 ....................................... June 6, 2019 ....................................... June 6, 2019 ....................................... June 7, 2019 ....................................... June 7, 2019 ....................................... July 22, 2019 ...................................... 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. VA Central Office. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. 20 F Conference Center. The addresses of the meeting sites are: 20 F Conference Center, 20 F Street NW, Washington, DC; VA Central Office, 1100 First Street NE, Suite 600, Washington, DC. amozie on DSK9F9SC42PROD with NOTICES * Teleconference The purpose of the subcommittees is to provide advice on the scientific quality, budget, safety and mission relevance of investigator-initiated research applications submitted for VA merit review evaluation. Applications submitted for review include various medical specialties within the general areas of biomedical, behavioral and clinical science research. These subcommittee meetings will be closed to the public for the review, discussion, and evaluation of initial and renewal research applications, which involve reference to staff and consultant critiques of research applications. Discussions will deal with scientific VerDate Sep<11>2014 18:08 Apr 29, 2019 Jkt 247001 merit of each application and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted release of proprietary processes and data. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research applications. As provided by subsection 10(d) of Public Law 92–463, as amended by Public Law 94–409, closing the subcommittee meetings is in accordance with Title 5 U.S.C. 552b(c) (6) and (9)(B). Those who would like to obtain a copy of the minutes from the closed PO 00000 Frm 00113 Fmt 4703 Sfmt 9990 subcommittee meetings and rosters of the subcommittee members should contact Holly Krull, Ph.D., Manager, Merit Review Program (10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 632–8522 or email at holly.krull@va.gov. Dated: April 25, 2019. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2019–08695 Filed 4–29–19; 8:45 am] BILLING CODE P E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 84, Number 83 (Tuesday, April 30, 2019)]
[Notices]
[Page 18344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08695]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review Board 
Notice of Meetings

    The Department of Veterans Affairs (VA) gives notice under Federal 
Advisory Committee Act that the subcommittees of the Joint Biomedical 
Laboratory Research and Development and Clinical Science Research and 
Development Services Scientific Merit Review Board (JBL/CS SMRB) will 
meet from 8 a.m. to 5 p.m. on the dates indicated below (unless 
otherwise listed):

------------------------------------------------------------------------
         Subcommittee                  Date               Location
------------------------------------------------------------------------
Oncology-A/D..................  May 17, 2019.....  20 F Conference
                                                    Center.
Cellular & Molecular Medicine.  May 20, 2019.....  20 F Conference
                                                    Center.
Endocrinology-A...............  May 21, 2019.....  20 F Conference
                                                    Center.
Neurobiology-C................  May 21, 2019.....  20 F Conference
                                                    Center.
Mental Health & Behavioral      May 22, 2019.....  20 F Conference
 Sciences-A.                                        Center.
Oncology-B/E..................  May 22, 2019.....  20 F Conference
                                                    Center.
Surgery.......................  May 22, 2019.....  20 F Conference
                                                    Center.
Cardiovascular Studies-A......  May 23, 2019.....  20 F Conference
                                                    Center.
Infectious Diseases-A.........  May 23, 2019.....  20 F Conference
                                                    Center.
Oncology-C....................  May 23, 2019.....  20 F Conference
                                                    Center.
Endocrinology-B...............  May 29, 2019.....  20 F Conference
                                                    Center.
Immunology & Dermatology-A....  May 29, 2019.....  20 F Conference
                                                    Center.
Neurobiology-B................  May 29, 2019.....  20 F Conference
                                                    Center.
Infectious Diseases-B.........  May 30, 2019.....  20 F Conference
                                                    Center.
Pulmonary Medicine............  May 30, 2019.....  20 F Conference
                                                    Center.
Gulf War Research.............  May 30, 2019.....  20 F Conference
                                                    Center.
Neurobiology-A................  May 31, 2019.....  20 F Conference
                                                    Center.
Neurobiology-E................  May 31, 2019.....  20 F Conference
                                                    Center.
Gastroenterology..............  June 4, 2019.....  20 F Conference
                                                    Center.
Nephrology....................  June 4, 2019.....  20 F Conference
                                                    Center.
* Neurobiology-F..............  June 5, 2019.....  VA Central Office.
Cardiovascular Studies-B......  June 6, 2019.....  20 F Conference
                                                    Center.
Epidemiology..................  June 6, 2019.....  20 F Conference
                                                    Center.
Mental Health & Behavioral      June 6, 2019.....  20 F Conference
 Sciences-B.                                        Center.
Hematology....................  June 7, 2019.....  20 F Conference
                                                    Center.
Neurobiology-D................  June 7, 2019.....  20 F Conference
                                                    Center.
Eligibility...................  July 22, 2019....  20 F Conference
                                                    Center.
------------------------------------------------------------------------
The addresses of the meeting sites are: 20 F Conference Center, 20 F
 Street NW, Washington, DC; VA Central Office, 1100 First Street NE,
 Suite 600, Washington, DC..
------------------------------------------------------------------------
* Teleconference

    The purpose of the subcommittees is to provide advice on the 
scientific quality, budget, safety and mission relevance of 
investigator-initiated research applications submitted for VA merit 
review evaluation. Applications submitted for review include various 
medical specialties within the general areas of biomedical, behavioral 
and clinical science research.
    These subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
applications, which involve reference to staff and consultant critiques 
of research applications. Discussions will deal with scientific merit 
of each application and qualifications of personnel conducting the 
studies, the disclosure of which would constitute a clearly unwarranted 
release of proprietary processes and data. Additionally, premature 
disclosure of research information could significantly obstruct 
implementation of proposed agency action regarding the research 
applications. As provided by subsection 10(d) of Public Law 92-463, as 
amended by Public Law 94-409, closing the subcommittee meetings is in 
accordance with Title 5 U.S.C. 552b(c) (6) and (9)(B).
    Those who would like to obtain a copy of the minutes from the 
closed subcommittee meetings and rosters of the subcommittee members 
should contact Holly Krull, Ph.D., Manager, Merit Review Program 
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, 
Washington, DC 20420, at (202) 632-8522 or email at [email protected].

    Dated: April 25, 2019.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-08695 Filed 4-29-19; 8:45 am]
 BILLING CODE P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.